NSE filing, NSE: ICICIBANK. Summary written from the filing by ALFA Finder's alert engine.
ICICI Bank Ltd: key numbers
- Share price
- ₹1,377.60
- Market cap
- ₹9,89,105 Cr
- Revenue (annual)
- ₹1,95,218 Cr
- Net profit (annual)
- ₹54,208 Cr
- P/E (TTM)
- 16.8×Sector 19.7×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 34.68%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ICICI Bank Ltd
All →ICICI Bank Credit Rating
ICRA and CARE reaffirmed ICICI Bank's credit ratings on October 23, 2026, with ICRA withdrawing ratings on matured instruments. The filing discloses no new money raised.
ICICI Bank Employee Stock Options
ICICI Bank reissued 24,096 forfeited shares under its ESUS scheme on 22 Oct 2026. No issue price is disclosed in the filing.
ICICI Bank Other Announcement
ICICI Bank Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
ICICI Bank Management Change
ICICI Bank's Board approved seeking RBI approval for the continuation of Mr. Pradeep Kumar Sinha as Non-executive Part-time Chairperson until February 16, 2029.
ICICI Bank Earnings Call Transcript: Key Takeaways
Strong core operating profit growth of 21.8% YoY driven by robust loan expansion despite moderate NIM compression.
ICICI Bank Investor Presentation: Key Takeaways
ICICI Bank reported strong Q2-2027 performance with PAT up 20.1% YoY to ₹148.43 bn. Growth was driven by robust credit demand and stable asset quality.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.